Immunomodulatory role of prolactin in diabetes development

Autoimmunity Reviews

Volumn 9, Issue 1, 2009, Pages 23-27

  Cejkova, P ^a   Fojtikova, M ^b   Cerna, M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

Author keywords

Immunity; Monocytes; Prolactin; T1D; T2D

Indexed keywords

IMMUNOGLOBULIN; PROLACTIN;

B LYMPHOCYTE; CLINICAL FEATURE; DISEASE COURSE; GENE CONTROL; GENETIC TRANSCRIPTION; HUMAN; HYPERPROLACTINEMIA; IMMUNE DEFICIENCY; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE;

ANTIBODIES; B-LYMPHOCYTES; CELL DIFFERENTIATION; DIABETES MELLITUS; HUMANS; HYPERPROLACTINEMIA; INFLAMMATION MEDIATORS; INSULIN; INSULIN-SECRETING CELLS; NEUROIMMUNOMODULATION; PROLACTIN; T-LYMPHOCYTES;

EID: 69649084224     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.02.031     Document Type: Review

References (40)

1. Ben Jonathan N., Mershon J.L., Allen D.L., and Steinmetz R.W. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 17 6 (1996) 639-669
2. Brand J.M., Frohn C., Cziupka K., Brockmann C., Kirchner H., and Luhm J. Prolactin triggers pro-inflammatory immune responses in peripheral immune cells. Eur Cytokine Netw 15 2 (2004) 99-104
3. Orbach H., and Shoenfeld Y. Hyperprolactinemia and autoimmune diseases. Autoimmun Rev 6 8 (2007) 537-542
4. McMurray R.W. Bromocriptine in rheumatic and autoimmune diseases. Semin Arthritis Rheum 31 1 (2001) 21-32
5. Knip M., and Siljander H. Autoimmune mechanisms in type 1 diabetes. Autoimmun Rev 7 7 (2008) 550-557
6. Yanaba K., Bouaziz J.D., Matsushita T., Magro C.M., St Clair E.W., and Tedder T.F. B-lymphocyte contributions to human autoimmune disease. Immunol Rev 223 (2008) 284-299
7. Zipris D. Innate immunity and its role in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 15 4 (2008) 326-331
8. Meyer-Bahlburg A., and Rawlings D.J. B cell autonomous TLR signaling and autoimmunity. Autoimmun Rev 7 4 (2008) 313-316
9. Hurst J., and von Landenberg P. Toll-like receptors and autoimmunity. Autoimmun Rev 7 3 (2008) 204-208
10. Wellen K.E., and Hotamisligil G.S. Inflammation, stress, and diabetes. J Clin Invest 115 5 (2005) 1111-1119
11. Zick Y. Role of Ser/Thr kinases in the uncoupling of insulin signaling. Int J Obes Relat Metab Disord 27 Suppl 3 (2003) S56-S60
12. Mooney R.A., Senn J., Cameron S., Inamdar N., Boivin L.M., Shang Y., et al. Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance. J Biol Chem 276 28 (2001) 25889-25893
13. Emanuelli B., Peraldi P., Filloux C., Chavey C., Freidinger K., Hilton D.J., et al. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice. J Biol Chem 276 51 (2001) 47944-47949
14. Perreault M., and Marette A. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med 7 10 (2001) 1138-1143
15. Reem G.H., Ray D.W., and Davis J.R. The human prolactin gene upstream promoter is regulated in lymphoid cells by activators of T-cells and by cAMP. J Mol Endocrinol 22 3 (1999) 285-292
16. Gerlo S., Verdood P., Gellersen B., Hooghe-Peters E.L., and Kooijman R. Mechanism of prostaglandin (PG)E2-induced prolactin expression in human T cells: cooperation of two PGE2 receptor subtypes, E-prostanoid (EP) 3 and EP4, via calcium- and cyclic adenosine 5′-monophosphate-mediated signaling pathways. J Immunol 173 10 (2004) 5952-5962
17. Gerlo S., Verdood P., Hooghe-Peters E.L., and Kooijman R. Modulation of prolactin expression in human T lymphocytes by cytokines. J Neuroimmunol 162 1-2 (2005) 190-193
18. Stevens A., Ray D., Alansari A., Hajeer A., Thomson W., Donn R., et al. Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus. Arthritis Rheum 44 10 (2001) 2358-2366
19. Fojtikova M., Cerna M., Cejkova P., Ruzickova S., and Dostal C. Extrapituitary prolactin promoter polymorphism in Czech patients with systemic lupus erythematosus and rheumatoid arthritis. Ann. Rheum. Dis. 66 5 (2007) 706-707
20. Vera-Lastra O., Jara L.J., and Espinoza L.R. Prolactin and autoimmunity. Autoimmun Rev 1 6 (2002) 360-364
21. Brelje T.C., Stout L.E., Bhagroo N.V., and Sorenson R.L. Distinctive roles for prolactin and growth hormone in the activation of signal transducer and activator of transcription 5 in pancreatic islets of langerhans. Endocrinology 145 9 (2004) 4162-4175
22. Lahat N., Miller A., Shtiller R., and Touby E. Differential effects of prolactin upon activation and differentiation of human B lymphocytes. J Neuroimmunol 47 1 (1993) 35-40
23. Hooghe R., Dogusan Z., Martens N., Velkeniers B., and Hooghe-Peters E.L. Effects of prolactin on signal transduction and gene expression: possible relevance for systemic lupus erythematosus. Lupus 10 10 (2001) 719-727
24. Dogusan Z., Hooghe-Peters E.L., Berus D., Velkeniers B., and Hooghe R. Expression of SOCS genes in normal and leukemic human leukocytes stimulated by prolactin, growth hormone and cytokines. J Neuroimmunol 109 1 (2000) 34-39
25. Cwikel S., Silvian-Drachsler I., Prolov L., Hooghe-Peters E.L., and Merchav S. Prolactin-induced expression of cytokine-inducible SH2 signaling inhibitors in human hematopoietic progenitors. Exp Hematol 29 8 (2001) 937-942
26. De Bellis A., Bizzarro A., Pivonello R., Lombardi G., and Bellastella A. Prolactin and autoimmunity. Pituitary 8 1 (2005) 25-30
27. Majumder B., Biswas R., and Chattopadhyay U. Prolactin regulates antitumor immune response through induction of tumoricidal macrophages and release of IL-12. Int J Cancer 97 4 (2002) 493-500
28. Mukherjee P., Mastro A.M., and Hymer W.C. Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes. Endocrinology 126 1 (1990) 88-94
29. Matera L., Mori M., Geuna M., Buttiglieri S., and Palestro G. Prolactin in autoimmunity and antitumor defence. J Neuroimmunol 109 1 (2000) 47-55
30. Matera L., Mori M., and Galetto A. Effect of prolactin on the antigen presenting function of monocyte-derived dendritic cells. Lupus 10 10 (2001) 728-734
31. Jara L.J., Benitez G., and Medina G. Prolactin, dendritic cells, and systemic lupus erythematosus. Autoimmun Rev 7 3 (2008) 251-255
32. Brelje T.C., Scharp D.W., Lacy P.E., Ogren L., Talamantes F., Robertson M., et al. Effect of homologous placental lactogens, prolactins, and growth hormones on islet B-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy. Endocrinology 132 2 (1993) 879-887
33. Stout L.E., Svensson A.M., and Sorenson R.L. Prolactin regulation of islet-derived INS-1 cells: characteristics and immunocytochemical analysis of STAT5 translocation. Endocrinology 138 4 (1997) 1592-1603
34. Freemark M., Avril I., Fleenor D., Driscoll P., Petro A., Opara E., et al. Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance. Endocrinology 143 4 (2002) 1378-1385
35. Fleenor D.E., and Freemark M. Prolactin induction of insulin gene transcription: roles of glucose and signal transducer and activator of transcription 5. Endocrinology 142 7 (2001) 2805-2810
36. Amaral M.E., Cunha D.A., Anhe G.F., Ueno M., Carneiro E.M., Velloso L.A., et al. Participation of prolactin receptors and phosphatidylinositol 3-kinase and MAP kinase pathways in the increase in pancreatic islet mass and sensitivity to glucose during pregnancy. J Endocrinol 183 3 (2004) 469-476
37. Aguirre V., Werner E.D., Giraud J., Lee Y.H., Shoelson S.E., and White M.F. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem 277 2 (2002) 1531-1537
38. Schernthaner G., Prager R., Punzengruber C., and Luger A. Severe hyperprolactinaemia is associated with decreased insulin binding in vitro and insulin resistance in vivo. Diabetologia 28 3 (1985) 138-142
39. Dostal C., Moszkorzova L., Musilova L., Lacinova Z., Marek J., and Zvarova J. Serum prolactin stress values in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 62 5 (2003) 487-488
40. Breuel K.F., Kougias P., Rice P.J., Wei D., De Ponti K., Wang J., et al. Anterior pituitary cells express pattern recognition receptors for fungal glucans: implications for neuroendocrine immune involvement in response to fungal infections. Neuroimmunomodulation 11 1 (2004) 1-9